Published Erratum
JAMA neurology. 2026 Jun 15:e261881. DOI:10.1001/jamaneurol.2026.1881 2026
Bridgette Jeanne Billioux,Cavan Reilly,Collin van Ryn et al.
Bridgette Jeanne Billioux et al.
Importance: Ebola virus disease (EVD) causes multiorgan damage and is highly fatal. EVD's neurological impact among survivors remains poorly characterized due to limited neurological assessment capabilities in the remote ...
Daniel M Goldenholz,Shira R Goldenholz,Hillary Mullan et al.
Daniel M Goldenholz et al.
Published Erratum
JAMA neurology. 2026 Jun 8. DOI:10.1001/jamaneurol.2026.1890 2026
Personalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke: A Randomized Clinical Trial [0.03%]
急性缺血性卒中血管内治疗后血压个体化目标值设定随机临床试验
Pol Camps-Renom,Marina Guasch-Jiménez,Juan Álvarez-Cienfuegos et al.
Pol Camps-Renom et al.
Importance: Optimal blood pressure (BP) management after successful endovascular therapy for acute ischemic stroke remains uncertain, as intensive lowering has shown no benefit or potential harm in prior trials. ...
Lesley Y Wu,Tessa du Toit,Tatiana Georgiades et al.
Lesley Y Wu et al.
Importance: Accurate diagnosis of neurodegenerative movement disorders is challenging because of a lack of in vivo biomarkers, overlapping clinical features, and a delay in the emergence of pathognomonic features. ...
Complete Remission of Cavin-4 Immunoglobulin G Rippling Muscle Disease After Rituximab Therapy [0.03%]
利妥昔单抗治疗Cav-4免疫球蛋白G型断续肌病后完全缓解
Tony Zhang,William J Litchy,Divyanshu Dubey
Tony Zhang
Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion: A Randomized Clinical Trial [0.03%]
组织型纤溶酶原激活剂与小剂量替奈普酶治疗大血管闭塞急性缺血性脑卒中的随机临床试验
Manabu Inoue,Teruyuki Hirano,Mayumi Fukuda-Doi et al.
Manabu Inoue et al.
Importance: Tenecteplase has advantages over standard-dose alteplase for acute ischemic stroke. A low-dose alteplase regimen (0.6 mg/kg) remains the standard in Japan and is commonly used in several Asian countries. ...
Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio [0.03%]
FDA批准的Lumipulse P-Tau217/β-淀粉样蛋白1-42血浆比率临床表现的变异性
Alicia Algeciras-Schimnich,Joshua A Bornhorst,Daniel J Figdore et al.
Alicia Algeciras-Schimnich et al.
Effect of Electroacupuncture on Postherpetic Neuralgia: A Randomized Clinical Trial [0.03%]
电针治疗带状疱疹后神经痛的疗效观察：随机对照试验
Lu Chen,Qianyan Liu,Lixia Pei et al.
Lu Chen et al.
Importance: Postherpetic neuralgia (PHN) is a refractory neuropathic pain condition with limited therapeutic options. Although electroacupuncture has demonstrated potential analgesic effects, high-quality evidence from ri...